Case Report: Markedly Long-Term Preservation of Pancreatic β‐Cell Function in a Subject With Elderly Onset of Type 1 Diabetes Mellitus Showing High-Titer Autoimmune Antibodies for Over 4 Years

Type 1 diabetes mellitus (T1DM) is mainly triggered by autoimmune β-cell destruction, usually leading to absolute insulin deficiency. Regarding the speed of β-cell destruction, there are large variations depending on age. In some adult cases, sufficient β-cell function is sometimes retained for a re...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 12; p. 752423
Main Authors Shigemoto, Ryo, Anno, Takatoshi, Kawasaki, Fumiko, Kaku, Kohei, Kaneto, Hideaki
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 25.11.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Type 1 diabetes mellitus (T1DM) is mainly triggered by autoimmune β-cell destruction, usually leading to absolute insulin deficiency. Regarding the speed of β-cell destruction, there are large variations depending on age. In some adult cases, sufficient β-cell function is sometimes retained for a relatively long period and eventually they become dependent on insulin for survival. It is known that even in subjects with T1DM showing high titers of such antibodies, insulin secretory capacity is preserved under several conditions such as “honeymoon” period and slowly progressive T1DM (SPIDDM). Herein, we reported the acute onset T1DM subject with long-term preservation of β-cell function, although his anti-GAD antibody and anti-IA-2 antibody titers were very high for more than 4 years. This case is very important in that his β-cell function was preserved with dipeptidyl peptidase-4 inhibitor alone. This means that there are large variations in the speed of β-cell destruction in the onset of T1DM.
AbstractList Type 1 diabetes mellitus (T1DM) is mainly triggered by autoimmune β-cell destruction, usually leading to absolute insulin deficiency. Regarding the speed of β-cell destruction, there are large variations depending on age. In some adult cases, sufficient β-cell function is sometimes retained for a relatively long period and eventually they become dependent on insulin for survival. It is known that even in subjects with T1DM showing high titers of such antibodies, insulin secretory capacity is preserved under several conditions such as “honeymoon” period and slowly progressive T1DM (SPIDDM). Herein, we reported the acute onset T1DM subject with long-term preservation of β-cell function, although his anti-GAD antibody and anti-IA-2 antibody titers were very high for more than 4 years. This case is very important in that his β-cell function was preserved with dipeptidyl peptidase-4 inhibitor alone. This means that there are large variations in the speed of β-cell destruction in the onset of T1DM.
Type 1 diabetes mellitus (T1DM) is mainly triggered by autoimmune β-cell destruction, usually leading to absolute insulin deficiency. Regarding the speed of β-cell destruction, there are large variations depending on age. In some adult cases, sufficient β-cell function is sometimes retained for a relatively long period and eventually they become dependent on insulin for survival. It is known that even in subjects with T1DM showing high titers of such antibodies, insulin secretory capacity is preserved under several conditions such as "honeymoon" period and slowly progressive T1DM (SPIDDM). Herein, we reported the acute onset T1DM subject with long-term preservation of β-cell function, although his anti-GAD antibody and anti-IA-2 antibody titers were very high for more than 4 years. This case is very important in that his β-cell function was preserved with dipeptidyl peptidase-4 inhibitor alone. This means that there are large variations in the speed of β-cell destruction in the onset of T1DM.Type 1 diabetes mellitus (T1DM) is mainly triggered by autoimmune β-cell destruction, usually leading to absolute insulin deficiency. Regarding the speed of β-cell destruction, there are large variations depending on age. In some adult cases, sufficient β-cell function is sometimes retained for a relatively long period and eventually they become dependent on insulin for survival. It is known that even in subjects with T1DM showing high titers of such antibodies, insulin secretory capacity is preserved under several conditions such as "honeymoon" period and slowly progressive T1DM (SPIDDM). Herein, we reported the acute onset T1DM subject with long-term preservation of β-cell function, although his anti-GAD antibody and anti-IA-2 antibody titers were very high for more than 4 years. This case is very important in that his β-cell function was preserved with dipeptidyl peptidase-4 inhibitor alone. This means that there are large variations in the speed of β-cell destruction in the onset of T1DM.
Author Anno, Takatoshi
Kaneto, Hideaki
Shigemoto, Ryo
Kaku, Kohei
Kawasaki, Fumiko
AuthorAffiliation 2 Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School , Kurashiki , Japan
1 Department of General Internal Medicine 1, Kawasaki Medical School , Okayama , Japan
AuthorAffiliation_xml – name: 2 Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School , Kurashiki , Japan
– name: 1 Department of General Internal Medicine 1, Kawasaki Medical School , Okayama , Japan
Author_xml – sequence: 1
  givenname: Ryo
  surname: Shigemoto
  fullname: Shigemoto, Ryo
– sequence: 2
  givenname: Takatoshi
  surname: Anno
  fullname: Anno, Takatoshi
– sequence: 3
  givenname: Fumiko
  surname: Kawasaki
  fullname: Kawasaki, Fumiko
– sequence: 4
  givenname: Kohei
  surname: Kaku
  fullname: Kaku, Kohei
– sequence: 5
  givenname: Hideaki
  surname: Kaneto
  fullname: Kaneto, Hideaki
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34899702$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1uEzEUx0eoiJbSA7BBXrJJ8MeMZ4YFUhVaWilVKhqEWFke-03iMLGD7QnKjiNwFq7AnkNwEpykRS0S3vjjvf_v2c__p9mBdRay7DnBQ8aq-lVrlst-SDElw7KgOWWPsiPCeT5glOYH99aH2UkIC5xGXjPGiifZIcurui4xPcp-jmQA9B5WzsfX6Er6z6C7DRo7OxtMwS_RtYcAfi2jcRa5Fl1LqzykrUK_fvz-9n0EXYfOe6t2CcYiiW76ZgEqoo8mztFZp8En4sQGiFvAdLMCRNBbIxuIENBVApjYB3Qzd1-NnaELM5sPpiaCR6d9dNtnWkCnNprGaZMUrfNosk7hHH0C6cOz7HEruwAnt_Nx9uH8bDq6GIwn7y5Hp-OBynkRB0rVDGsJdYsZLtsSNFQVpRjThiitJcEF1EzzllPgShUF8JxA0eYt1rkGyo6zyz1XO7kQK2-W0m-Ek0bsDpyfCelTYzoQUHBZlYxXRUVzUrCaAGs0V4UuGWFNm1hv9qxV3yxBK7DRy-4B9GHEmrmYubWoOMdFvb3My1uAd196CFEsTVCpl9KC64OgnGBc1piWKfXF_Vp_i9y5ICWU-wTlXQgeWqFM3P14Km06QbDYWk7sLCe2lhN7yyUl-Ud5B_-_5g_kKN8C
CitedBy_id crossref_primary_10_7759_cureus_25746
crossref_primary_10_1155_2022_9363543
Cites_doi 10.1111/j.2040-1124.2010.00074.x
10.2337/dbi20-0017
10.2337/dc08-1987
10.2337/dc21-ad09
10.2147/DMSO.S191007
10.1155/2014/851378
ContentType Journal Article
Copyright Copyright © 2021 Shigemoto, Anno, Kawasaki, Kaku and Kaneto.
Copyright © 2021 Shigemoto, Anno, Kawasaki, Kaku and Kaneto 2021 Shigemoto, Anno, Kawasaki, Kaku and Kaneto
Copyright_xml – notice: Copyright © 2021 Shigemoto, Anno, Kawasaki, Kaku and Kaneto.
– notice: Copyright © 2021 Shigemoto, Anno, Kawasaki, Kaku and Kaneto 2021 Shigemoto, Anno, Kawasaki, Kaku and Kaneto
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3389/fimmu.2021.752423
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_e56a87368582415391e3bd6c5d7313bf
PMC8660592
34899702
10_3389_fimmu_2021_752423
Genre Case Reports
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
CGR
CUY
CVF
ECM
EIF
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c465t-cc930dae9f0307f7ede8822002b1cdda105e93d6f62e6cc55e641e5f4f0d4de23
IEDL.DBID M48
ISSN 1664-3224
IngestDate Wed Aug 27 01:23:01 EDT 2025
Thu Aug 21 18:39:33 EDT 2025
Thu Jul 10 19:15:51 EDT 2025
Thu Jan 02 22:56:01 EST 2025
Tue Jul 01 00:53:28 EDT 2025
Thu Apr 24 23:02:38 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords anti-GAD antibody
type 1 diabetes mellitus
elderly onset
β-cell function
anti-IA-2 antibody
autoimmune antibody
Language English
License Copyright © 2021 Shigemoto, Anno, Kawasaki, Kaku and Kaneto.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-cc930dae9f0307f7ede8822002b1cdda105e93d6f62e6cc55e641e5f4f0d4de23
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Edited by: Attila Mócsai, Semmelweis University, Hungary
This article was submitted to Autoimmune and Autoinflammatory Disorders, a section of the journal Frontiers in Immunology
Reviewed by: Mei-Ling Yang, Yale University, United States; Pongpan Tanajak, Apinop Wetchakham Hospital (Keang Khoi Medical Center), Thailand
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2021.752423
PMID 34899702
PQID 2610079027
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_e56a87368582415391e3bd6c5d7313bf
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8660592
proquest_miscellaneous_2610079027
pubmed_primary_34899702
crossref_citationtrail_10_3389_fimmu_2021_752423
crossref_primary_10_3389_fimmu_2021_752423
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-11-25
PublicationDateYYYYMMDD 2021-11-25
PublicationDate_xml – month: 11
  year: 2021
  text: 2021-11-25
  day: 25
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2021
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References (B1) 2021; 44
Mortensen (B2) 2009; 32
Nishimura (B3) 2019; 12
Buzzetti (B4) 2020; 69
Seino (B5) 2010; 1
Pecheur (B6) 2014; 2014
References_xml – volume: 1
  year: 2010
  ident: B5
  article-title: Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
  publication-title: J Diabetes Investig
  doi: 10.1111/j.2040-1124.2010.00074.x
– volume: 69
  year: 2020
  ident: B4
  article-title: Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel
  publication-title: Diabetes
  doi: 10.2337/dbi20-0017
– volume: 32
  year: 2009
  ident: B2
  article-title: New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1987
– volume: 44
  year: 2021
  ident: B1
  article-title: 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021
  publication-title: Diabetes Care
  doi: 10.2337/dc21-ad09
– volume: 12
  year: 2019
  ident: B3
  article-title: Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge and Future Perspectives
  publication-title: Diabetes Metab Syndr Obes
  doi: 10.2147/DMSO.S191007
– volume: 2014
  year: 2014
  ident: B6
  article-title: Characteristics and Determinants of Partial Remission in Children With Type 1 Diabetes Using the Insulin-Dose-Adjusted A1C Definition
  publication-title: J Diabetes Res
  doi: 10.1155/2014/851378
SSID ssj0000493335
Score 2.3001451
Snippet Type 1 diabetes mellitus (T1DM) is mainly triggered by autoimmune β-cell destruction, usually leading to absolute insulin deficiency. Regarding the speed of...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 752423
SubjectTerms Aged
anti-GAD antibody
anti-IA-2 antibody
Autoantibodies - immunology
Autoantigens - immunology
autoimmune antibody
Diabetes Mellitus, Type 1 - immunology
Diabetes Mellitus, Type 1 - pathology
Disease Progression
elderly onset
Humans
Immunology
Insulin-Secreting Cells - pathology
Male
type 1 diabetes mellitus
β-cell function
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NitRAEG5kQfAi_hv_KMGTEDdJ_2TibRx2WMR1BWdxPYWku7ITmU3EJMjefASfxVfw7kP4JFYlmWFGRC9eMz1J01911fcl1VVCPAkmeZQ443xrLfoKc-fnMWmepMhC5bjvtOXzzkevzeGJenmqT7dafXFO2FAeeFi4fdQmm8R9mXQONjIJUebOWO1iGcq8YO9LMW9LTH0YeK-UUg-fMUmFJftFeX7ekR6MwmexZhKxE4j6ev1_Ipm_50puBZ_5NXF1ZI0wHWZ7XVzC6oa4PPSRvLgpvs8oFsHApZ8DH79Bt7qAV3V15i_I9QInWqzfvkJdwBvCumeLFn58-_nl6wxXK5hTiOsHlBVkQB6FX9HAu7JdwgH38qY7HlcNtnwDlq8QwphP08AR1_VsuwbeLuvPFA2B80f8BZ9vhmnX1rwsFcK0asu85sRFILIMx7SPQMF72m3NLXEyP1jMDv2xO4NvldEtgZvIwGWYFOwnihgdElvnnI88tM5lRNwwkc4UJkJjrdZoVIi6UEXglMNI3hZ7VV3hXQGElZIys-R7SK6TAHImYt0pTVJwGzRPBGuoUjuWLucOGquUJAyjm_bopoxuOqDriaebv3wc6nb8bfALxn8zkEtu9xfIENPRENN_GaInHq-tJ6Utyt9dsgrrrklJpBITS4Io9sSdwZo2j5KKBG8cRJ6Id-xsZy67v1Tlsi8DPjEkRZPo3v-Y_H1xhdeDD1lG-oHYaz91-JDYVps_6jfWL5TzKwo
  priority: 102
  providerName: Directory of Open Access Journals
Title Case Report: Markedly Long-Term Preservation of Pancreatic β‐Cell Function in a Subject With Elderly Onset of Type 1 Diabetes Mellitus Showing High-Titer Autoimmune Antibodies for Over 4 Years
URI https://www.ncbi.nlm.nih.gov/pubmed/34899702
https://www.proquest.com/docview/2610079027
https://pubmed.ncbi.nlm.nih.gov/PMC8660592
https://doaj.org/article/e56a87368582415391e3bd6c5d7313bf
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LjtNAEG0Ng5DYIP5jPqNCYoXkwXbb7RgJoRBNGCHCIJGIsLLs_kyMPDbEtiA7jsBZuAJ7DsFJqLKdiKCIFRsv7PZH_bq63mtXVzH20BmkXqSEsqWU2vZ1quw0RM0TmcT1FdWdlrTfefJanMz8l_NgvsfW5a36Dqx2SjuqJzVb5kdfPq2eocE_JcWJ_vaxyc7PG5R6nnsUBsQPLrCL6JhCKmgw6dn-h44Mc86D7t_m7ju3vFObxH8X8_w7gPIPjzS-yq70VBKGHfbX2J4urrNLXXHJ1Q32Y4QOCjqC_QRoT45W-QpelcWZPcX5GCj6Yr0kC6WBNzgAWgop4ef3X1-_jXSewxj9XtsgKyABnGZo3QbeZfUCjqnANz7xtKh0TQ8gTQsu9EE2FUwo2WfdVPB2UX5GFwkUVGJPadMzDJu6pG4pNAyLOktLimYEZNBwisYFPrxHE6xustn4eDo6sfuSDbb0RVAj4hF3VKIjQ5OHCbXSSOEpECR1pVIJsjkdcSWM8LSQMgi08F0dGN84ylfa47fYflEW-oABYuVznkickFDDoypSwiMxykVkqDaaxZw1VLHs85lTWY08Rl1D6MYtujGhG3foWuzR5paPXTKPfzV-TvhvGlIe7vZEuTyLe7OOdSCSQdgm8ScqxCNX81QJGaiQuzw1FnuwHj0x2i39jEkKXTZVjMoV6VnkeKHFbnejafMq7qMKDh3PYuHWONv6lu0rRbZoc4MPBOrTyLvzPz7-LrtM_UE7L73gHtuvl42-jxSsTg_bpQs8vpi7h62R_Qb_RDXL
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Case+Report%3A+Markedly+Long-Term+Preservation+of+Pancreatic+%CE%B2%E2%80%90Cell+Function+in+a+Subject+With+Elderly+Onset+of+Type+1+Diabetes+Mellitus+Showing+High-Titer+Autoimmune+Antibodies+for+Over+4+Years&rft.jtitle=Frontiers+in+immunology&rft.au=Ryo+Shigemoto&rft.au=Takatoshi+Anno&rft.au=Fumiko+Kawasaki&rft.au=Kohei+Kaku&rft.date=2021-11-25&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-3224&rft.volume=12&rft_id=info:doi/10.3389%2Ffimmu.2021.752423&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e56a87368582415391e3bd6c5d7313bf
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon